ReviewCurrent opinion in lipidology2025
Orticumab: the potential to harness oxidized LDL to reduce coronary inflammation with plaque-targeted therapy.
Christopher J Farina et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it